2019 Legislative Session - Health Bill Summaries

Akerman LLP

Akerman LLP

The 2019 Florida legislative session was prolific in terms of proposed legislation that could impact the healthcare industry. A brief synopsis of some of these bills are detailed below. First, we have provided an analysis of legislation that passed and has become, or is expected to become, law in Florida. Next, we list very brief summaries of some of the legislation that did not pass, but may arise again in the future.

Bills that Passed:

Direct Health Agreements – HB 7: Section 627.24, Florida Statutes, establishes that direct primary care agreements are not insurance and are not subject to Insurance Code regulations. 

Currently, the direct healthcare agreement insurance exemption only applies to primary care services, and the exemption only applies when services are offered by primary care providers licensed under Florida Chapters 458 (medicine), 459 (osteopathic medicine), 460 (chiropractic medicine), 464 (nursing), and primary care group practices. 

HB 7 adds Chapter 466 (dentistry) to the list of providers authorized to offer direct care agreements. Additionally, the bill expands the scope of direct care agreements by authorizing provider groups to enter into direct care agreements for any healthcare service within their scope, competency and training.

If approved by the Governor, the legislation will take effect July 1, 2019.

Prescription Drug Importation Programs – HB 19: Establishes two programs allowing for the importation of, federal Food and Drug Administration approved, prescription drugs into the state and provides specific eligibility criteria for these drugs including importation processes, safety standards, testing requirements, and penalties for violation of these requirements. 

The first program established by the bill is the Canadian Prescription Drug Importation Program (CPDI Program), which is to be controlled by the Agency for Health Care Administration (AHCA). The CPDI Program’s main focus will be on providing savings and options for specific public programs, including, but not limited to: Medicaid recipients, county health department and free clinic clients, Department of Correction inmates, developmental disability center clients, and certain mental health facility clients. 

The other program, to be established by the Department of Business and Professional Regulation (DBPR) and the Department of Health (DOH), is the International Prescription Drug Importation Program (IPDI Program).

Both programs will be required to adhere to specific bonding requirements and federal product tracing requirements. Additionally, Florida’s ability to move forward with both programs is contingent upon federal approval.  

If approved by the Governor, the legislation will take effect July 1, 2019. 

Certificate of Need (Hospital Licensure) – HB 21: Revises AHCA rulemaking authority with respect to minimum standards for hospitals; requires hospitals that provide certain services to meet specified licensure requirements; revises duties and responsibilities of AHCA relating to issuance of licenses to health care facilities and health service providers, etc. 

For additional information see our prior blog on this topic, Florida Legislature Repeals its “Certificate of Need” Law

If approved by the Governor, the legislation will take effect July 1, 2019. 

Telehealth – HB 23: Establishes standards of practice for telehealth providers; authorizes certain telehealth providers to use telehealth to prescribe certain controlled substances under specified circumstances; provides registration requirements for out-of-state telehealth providers, etc. 

For additional information see our prior blog on this topic, 2019 Legislative Session – The Passage of Telehealth (HB 23)

If approved by the Governor, the legislation will take effect July 1, 2019. 

Aging Programs – SB 184: Currently, both the Department of Elder Affairs (DEA) and AHCA have rule making authority for certain programs where AHCA is the sole agency for licensing and inspection. These programs include hospice care, assisted living facilities, adult family care homes, and adult day care programs. This bill transfers all rule making for these programs to AHCA. 

Signed by the Governor April 26, 2019 – Chapter Law 2019-11; takes effect July 1, 2019. 

Health Plans – HB 322: The bill, as a result of 2018 federal regulations, amends the Florida Insurance Code relating to preexisting condition exclusions, essential health benefits, association health plans, and short-term limited duration. 

The bill, specifically:

  • Allows insurers to provide short-term health insurance for a period of up to 12 months with renewal opportunities up to a total coverage period of 36 months.
  • Specifies short-term health insurance in individual health insurance contracts is not subject to pre-existing condition provisions of the Florida Insurance Code.
  • Allows flexibility with some medical underwriting when offering short-term policies in a manner consistent with the use of these policies as bridges between comprehensive policies.
  • Requires the Florida Office of Insurance Regulation (OIR) to evaluate the state’s current essential health benefits (EHB) benchmark plan and complete a study comparing Florida’s plan and overall costs to EHB-benchmark plans in other states.
  • Increases insurer flexibility in designing EHB-compliant plans to meet the requirement of providing at least one service or coverage under each of the 10 EHBs by allowing insurers to replace one or more current EHBs coverages with those available in another state or by creating a new EHB plan that meets federal requirements. 

Finally, in the event of either Congress repealing or the Supreme Court invalidating the federal Patient Protection and Affordable Care Act, the bill requires insurers and health maintenance organizations (HMO) issuing major medical policies or contracts in Florida to offer at least one comprehensive major medical policy or contract that does not exclude, limit, deny, or delay coverage due to one or more preexisting medical conditions. 

This legislation, if approved by the Governor, will take effect upon becoming law. 

Nonemergency Medical Transportation Services – HB 411: HB 411 authorizes transportation network companies (TNC) in compliance with state and federal Medicaid requirements to provide nonemergency medical transportation services to Medicaid recipients if it (is):

  • Under contract with a Medicaid managed care plan;
  • Under contract with a transportation broker under contract with a Medicaid managed care plan;
  • Under contract with a transportation broker under contract with AHCA; or,
  • Receives referrals from a transportation broker under contract with a Medicaid managed care plan or AHCA. 

Additionally, the bill requires AHCA to update regulations, policies, etc. to reflect such authorizations and provides limits on requirements for TNCs and TNC drivers. 

If approved by the Governor the bill will take effect July 1, 2019. 

Insurer Guaranty Associations - HB 673: HB 673 adds life insurers, annuity insurers, and most HMOs to the Florida Life & Health Insurance Guaranty Association (FLAHIGA) assessment base to fund long-term care insurers in the event of impairment or insolvency; and provides for powers and duties of the Florida Health Maintenance Organization Consumer Assistance Plan (HMOCAP) in the event of a long-term care insurer impairment or insolvency. 

Additionally, the bill removes the interest rate cap on the FLAHIGA’s coverage for long-term care or any other health insurance benefit; clarifies that Medicare, Medicaid, and the Children’s Health Insurance Program are excluded from the FLAHIGA’s coverage and assessments; and, adds an exclusion for structured settlement annuity benefits to which a payee, or a beneficiary if the payee is deceased, has transferred his or her rights in a structured settlement factoring transaction. 

Lastly, the bill amends FLAHIGA’s powers and duties and adds two director positions to the FLAHIGA board. 

This legislation, if approved by the Governor, will take effect upon becoming law.

Office Surgeries – SB 732: Requires the DOH to issue an emergency order suspending or restricting the registration of certain facilities upon specified findings; requires an office in which a physician performs certain procedures or office surgeries to register with DOH; requires an office and physicians practicing at the office to meet certain financial responsibility requirements, etc. 

If approved by the Governor, the bill will take effect January 1, 2020.

Health Care – HB 843: SB 843 was the final companion to HB 7078. The final product includes, but is not limited to, provisions relating to:

  • The Dental Student Loan Repayment Program and the Donated Dental Services Program within DOH;
  • Patient safety and quality measures;
  • Relay of information from hospitals to patients and patients’ primary care providers or specialists;
  • Ambulatory and pediatric surgical centers;
  • Licensed facility observation reporting requirements; and,
  • Step-therapy protocols. 

Except as otherwise specified, the bill will take effect July 1, 2019, if approved by the Governor. 

Continuing Care Contracts – HB 1033: Revises and provides provisions related to continuing care contracts including financing, refinancing, procedures and standards for certificates of authority and provisional certificates, escrowed funds, provider acquisitions, expansion of facilities, rulemaking, filing of information, management contracts, minimum standards, procedures for providers not meeting standards, and composition of Continuing Care Advisory Council. 

If approved by the Governor the bill will take effect January 1, 2020.

Health Insurance – HB 1113: This bill creates the Patient Savings Act, allowing health insurers to create a voluntary shared savings incentive program to encourage insured individuals to shop for better (“higher quality and less expensive”) healthcare services and share any savings realized as a result; provides specific requirements for health insurers and HMOs offering these programs, requiring review and approval by OIR. 

Except as otherwise specified, the bill will take effect July 1, 2019, if approved by the Governor.

Mental Health – SB 1418: Requires service providers to disclose information from a clinical record under certain circumstances relating to threats to cause serious bodily injury or death; requires psychiatrists to disclose certain patient communications for purposes of notifying law enforcement agencies of certain threats; revises responsibilities of the Department of Education and the Statewide Office for Suicide Prevention, etc. 

If approved by the Governor the bill will take effect July 1, 2019.

Bills that did not Pass in 2019: 

Department of Health – SB 188/HB 7031: Revised healthcare practitioner licensure application requirements; revised licensure requirements for a person seeking licensure or certification as an osteopathic physician; revised requirements for examinations of dental hygienists; revised athletic trainer licensure requirements; revised qualifications for licensure as a massage therapist; revised requirements for licensure by endorsement or certification for specified professions, etc. 

Health Care Practitioners – HB 821: Authorized autonomous practice for specified healthcare practitioners; required the Board of Health or DOH to register physician assistants or advanced practice registered nurses if applicants met criteria; authorized such autonomous healthcare practitioners to perform specified acts without physician supervision or supervisory protocols; provided DOH appropriations and authorized positions. 

Health Care Licensing Requirements – HB 885/SB 1620: Exempted certain healthcare practitioners from specified licensing requirements when providing certain services to veterans in the state. 

Price Transparency in Contracts – HB 935/SB 1560: Prohibited insurer limitations on provider disclosures of cash price or availability of more affordable options; prohibited insurer requirements of insured payments in excess of price without insurance. 

Health Innovation Commission – HB 961/SB 1348: Created the Health Innovation Commission (“commissioner”) within AHCA; provided purpose, membership, meetings, and duties of commission; provided requirements for innovative proposals and requests for exemptions from specified laws or rules; required commission to review such proposals and provide its findings and decision to applicants within specified timeframe; required AHCA to submit an annual report to the Governor and Legislature; provided rulemaking authority; authorized positions and provided appropriations. 

Patient Access to Records – HB 1035: Required certain licensed facilities, providers, and healthcare practitioners to furnish and provide access to records and reports within a specified time frame after receiving a request; authorized facilities, providers, and practitioners to charge reasonable costs associated with reproducing or providing access to such records and reports. 

Dispensing Medicinal Drugs/Automated Pharmacy Systems – HB 1115/SB 1124: Authorized certain individuals to prescribe and dispense limited supplies of medicinal drugs to patients of hospital emergency departments or patients discharged from hospitals under certain circumstances; authorized community pharmacies to use automated pharmacy systems under certain circumstances; and, required the Board of Pharmacy to adopt rules. 

Nonmedical Changes to Prescription Drug Formularies – HB 1273/SB 1180: Required insurers issuing individual or group health insurance policies to provide certain notices to current and prospective insureds within a certain timeframe before the effective date of any change to a prescription drug formulary during a policy year; specified requirements for a notice of medical necessity that an insured’s treating physician may submit to the insurer within a certain timeframe; required small employer carriers to comply with certain requirements for any change to a prescription drug formulary under the health benefit plan, etc. 

Assisted Living Facilities (ALF) – HB 1349/SB 1592: Revised requirements and standards relating to ALF licensure, inspections, resident criteria and rights, staff training and continuing education. 

The bills passed during the 2019 Legislative Session that have not already been enacted await signature by Governor DeSantis. Once a bill is sent to the Governor, he has 15 days to sign or veto the legislation or it automatically passes into law. Akerman stands ready to assist should you have any questions regarding the pieces of legislation outlined herein.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Akerman LLP | Attorney Advertising

Written by:

Akerman LLP

Akerman LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.